Persephone Biosciences Company
Persephone Biosciences uses artificial intelligence to rapidly develop microbial based immunotherapies to enable a lifetime without cancer.
Technology:
COVID
Industry:
AI, Artificial Intelligence, Biotechnology, Early Drug Development, Health Care, Medical, Preclinical development, Preventive Tech, United States
Headquarters:
San Diego, California, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
8
Total Funding:
15120000
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-07-19
Last Funding Type:
Seed
Register and Claim Ownership